UF startup Myosin Therapeutics announced it has been selected to present at Biocom California’s Global Partnering & Investor Conference, taking place February 24–26, 2026 at The Lodge at Torrey Pines in La Jolla, California. In addition to one-on-one partnering meetings and investor discussions, Courtney Miller, PhD, Chief Executive Officer, will present on the company’s overall progress and future direction, with Karen Smith, MD, PhD, MBA, LLM, Chief Medical Officer, joining for investor and strategic partner engagements throughout the conference.
Read more about Myosin Therapeutics Invited To Present at Biocom California’s Global Partnering & Investor Conference.
